Note：All the information in this draft can be edited by authors. And the entry will be online only after authors edit and submit it.

1. Introduction

Suicides and suicidal behaviors are very important causes of mortality and morbidity and have become a serious global problem. Over 800,000 people die from suicide every year [1,2]. Suicide is one of the primary causes of death worldwide [3–5]. Moreover, it is one of the most devastating consequences of psychiatric disorders [6,7]. Suicide attempters are not a homogeneous group. There are many differences in their psychopathology, risk factor profiles, neurobiology, and neurochemistry; for example, oxidative stress plays an essential role in the pathophysiology of suicide, as do changes in brain function. These differences were observed via functional magnetic resonance imaging (fMRI) [8–10]. It is proved that depression and psychosis intensify suicidal ideation and suicide [11].

Many studies establish that lipid changes may be related to suicidality. There is a theory that serum lipid levels play an essential role in the pathogenesis of suicide [3,12–14]. A relationship between low serum cholesterol levels and suicide in patients with, e.g., depression, early psychosis, impulsivity, or violent behavior was established. [9,15–17].

One possible explanation is the association of monoamine oxidase (MAO) theory. The experimental studies demonstrated increased MAO A and MAO B activity in the hippocampus of mice [18,19]. Another theory assumes that lower cholesterol level may decrease membrane fluidity and cause an increase in the order of the membrane lipid bilayer. This might decrease serotonergic neurotransmission.

Cholesterol is a vital constituent of cellular membranes and plays an important role in membrane function. It was found dispersed in a non-random form in domains in membrane models [6,20–22]. These areas are assumed to be essential in the protection of the structure and function of the membrane. It has been indicated that these formations are membrane domains in which signalling from a neurotransmitter may arise like serotonin1A (5-HT1A) receptor [6,23,24].

Researchers demonstrated the major role of membrane cholesterol in the function of the 5-HT1A receptor [6,25–30]. It has been shown that the fluidity of lipids significantly controls the binding of serotonin (5-HT) in animal brain membranes. It is believed that lower levels of cholesterol increase the fluidity of cellular membrane. Alternatively, minimal exposure of the 5-HT receptors would be detected in the synaptic cleft [6,31,32].

It was shown that the percentage of suicide is three times higher in individuals with first-episode psychosis compared to the general population. Furthermore, suicide rates are higher throughout the progression of schizophrenia [9,33–36]. It has been demonstrated that 8.6% of suicidal behaviors occurred in patients with psychosis before their first visit to a hospital and 5.3% during the first year of treatment [9,13,14].

Furthermore, the severity of depression and bipolar disorder and are accompanied by a high suicidal risk [9,12,22,37].

Moreover, decreased blood levels of cholesterol have been related to violent [38,39] and aggressive behavior [40].

2. Total Cholesterol

For adults, total cholesterol levels must be lower than 200 mg/dL. The 220−239 mg level range is considered borderline high, and a reading of 240 mg/dL and above is thought high [41].

Bartoli et al. [42] found that persons who had attempted suicide had levels of total cholesterol (TC) (174.0 ± 45.7 mg/dL) lower than those who had not attempted suicide (193.9 ± 42.6 mg/dL) (p = 0.004). This finding was observed in violent (174.1 ± 46.2mg/dL) as well as non-violent (173.8 ± 46.1mg/dL) persons who had attempted suicide (p = 0.035 and 0.016, respectively).

Other researchers have observed that total esterified cholesterol measured at the time of psychiatric assessment shared a significant genetic similarity with the risk for attempting suicide (ρg = −0.64, p = 1.24 × 10⁻⁰⁴). They confirmed relationship between total cholesterol and suicidal risk was significantly mediated by ABCA-1-specific cholesterol efflux capacity [43].

Aguglia and co-workers [44] conducted a study with a sample of 632 attempts. They demonstrated that those who attempted high-lethality suicide had significantly lower total cholesterol. In another study, Aguglia et al. [45] focused on the predictors of relapse in the same group of individuals and noticed a correlation between lower TC serum levels and repeated suicide attempts [45].

In 2017, Messaoud and co-workers [36] performed research on Tunisian patients diagnosed with major depressive disorder (MDD). They observed a substantial decrease in plasma cholesterol levels in the group of suicidal depressive patients compared to controls.

Similar conclusions were reached by Segoviano-Mendoza et al., who found a significant decrease in total cholesterol serum levels in patients with MDD and suicide attempts compared to those without suicidal behavior. Moreover, lower cholesterol concentrations were significantly correlated with MDD and suicide attempts [6]. Chen et al. also found that the risk of suicidal death increased with lower serum TC levels across the three years preceding death by suicide [46].

Svensson et al. presented interesting findings resulting from their prospective study based on the Japan Public Health Center (JPHC) study from 1990 to 2012 [18]. This study demonstrated that high TC levels are related with an almost twofold increased risk of suicide in women in a large Japanese general population cohort (45,246 people) [18]. They found a considerably increased risk of suicide in females with high TC (HR = 1.90, 95% CI, 1.13–3.19) compared to women with normal TC. However, a correlation between TC levels and suicide in males was not found. [18].

In a study of 288 patients conducted by Ma et al. [47], 20.14% had attempted suicide in the previous month. The authors found lower total cholesterol, and more symptoms of psychosis. However, in their conclusions, these authors indicated that none of these significant results survived following the Bonferroni correction.

Reuter et al. [48] conducted an interesting study of veterans with suicidal ideation, a documented suicide attempt, or who had committed suicide between 2009 and 2015 and were included in the Suicide Prevention Coordinator database. They demonstrated that veterans with total cholesterol levels below 168 mg/dl had a greater risk for suicide compared to those with higher levels. The cholesterol levels of veterans reporting suicidal ideation or attempted suicide were significantly lower than the group reporting neither of these [F(2, 185) = 30.19, p < 0.001] [48]. By contrast, Capuzzi et al. showed that individuals with levels of total cholesterol below 160 mg/dL had lower rates of recent suicide attempts compared to those with values above 160 mg/dL [49]. Suenson et al. also reported negative correlations between serum total cholesterol (TC) and a compound variable of aggressive behavior in those who attempted suicide [40]. Ma et al. (2020) reported that persons who had made suicide attempts had higher total levels of TC compared with persons who had not [50].

3. Low-Density Lipoprotein

It is suggested that low-density lipoprotein cholesterol (LDL-c) should not exceed 100 milligrams per deciliter (mg/dL). Levels of 100 to 129 mg/dL are normal for individuals without heart diseases. A level of 130 to 159 mg/dL is borderline high and 160 to 189 mg/dL is high. A level of 190 mg/dL or higher is considered very high [41].

Aguglia et al. [44] showed that high lethality suicide attempters had considerably lower LDL compared to low lethality attempters and the control group [44].

Segoviano-Mendoza et al. [6] also reported that LDL-c serum levels were lowered significantly in the patients with MDD and a suicide attempt compared to those without suicidal behavior.

Suenson et al. [40] showed negative associations between LDL-c with a compound variable of aggressive state and between LDL-c and a compound variable of aggressive personality traits.

In another study an association was found between the incremental increase of low-density lipoprotein (HR = 1.11, 95% CI, 1.02–1.21) and an increased risk of suicide in females [18].

Among others, Ma et al. found a correlation between lower LDL-c and more psychotic symptoms showed [47].

Su et al. compared blood lipid profile markers between unipolar and bipolar depressed patients and in depressed patients with anhedonia or suicidal thoughts [51]. Patients with bipolar had significantly lower LDL-c. In turn, depressed patients with depression and anhedonia had considerably higher LDL-c levels compared to patients without anhedonia [51].

Additionally, Ayesa-Arriola et al. [52] showed that low levels of LDL-c ((OR = 0.99, 95% CI= 0.98−1.00) and depressive symptoms were correlated with suicidal behavior [52].

In the study conducted by Kavoor et al, which compared patients with schizophrenia with healthy controls, [53] LDL-c levels showed significant negative correlations with scores on impulsivity and suicidality [53].

Shaker et al. focused on the correlation between lipid levels and impulsivity in suicidal patients with major depressive disorder. They found that the LDL-c levels are important factors impacting the incidence of suicide and thus could be predictors for suicidality independent of impulsivity [54].

On the other hand, Ma et al. (2020) showed that suicide attempters had considerably higher levels of LDL-c compared with non-attempters [50].

4. Very Low-Density Lipoprotein

There are only a few studies that focused on changes of very low-density lipoprotein (VLDL) levels in suicide attempters. In the study conducted by Kavoor et al. [53] there is no correlation between scores on the Beck Scale for suicidal ideation (BSI) and VLDL levels in patients with schizophrenia. In contrast, Segoviano-Mendoza et al. [6] found a significant decrease in VLDL-cholesterol in patients with MDD and suicide attempts compared to those without suicidal behavior.

5. High Density Lipoprotein

It is suggested that high density lipoprotein (HDL) levels ought to be kept higher. HDL levels below 40 mg/dL are considered a most important risk factor for heart disease. Level from 41 mg/dL to 59 mg/dL is considered borderline low. The optimal range for HDL levels is 60 mg/dL or higher [41].

In the study conducted by Ma et al. suicide attempters had significantly lower high-density lipoprotein cholesterol (HDL-c) levels compared with non-attempters [49].

Similar results were reported by Loas et al., who found that a high level of suicidal ideation was associated with low levels of HDL [54].

Shaker et al. also found that low HDL level was significantly associated with suicidality and high suicide intent was associated with hopelessness. [55].

Likewise, suicide attempts were related to decreased HDL-C in the study performed by Zhao et al. [56].

Aguglia et al. [44] compared the low lethality group (LLSA) including 299 subjects with a group of high lethality suicide attempters (HLSA) including 133 subjects. The LLSA group exhibited higher HDL-c levels compared to HLSA group.

Su et al. had other conclusions [51]. In their study persons with suicidal thoughts had higher levels of HDL as compared with controls.

References

1. Daray, F.M.; Mann, J.J.; Sublette, M.E. How lipids may affect risk for suicidal behavior. Psychiatr. Res. 2018, 104, 16–23.
2. World Health Organization. Preventing Suicide: A Global Imperative. 2014. Available online: https://www.who.int/mental_health/suicide-prevention/world_report_2014/en/ (accessed on 10 November 2020).
3. Wu, S.; Ding, Y.; Wu, F.; Xie, G.; Hou, J.; Mao, P. Serum lipid levels and suicidality: A meta-analysis of 65 epidemiological studies. Psychiatry Neurosci. 2016, 41, 56–69.
4. Kay, M. Suicide is leading cause of death in young Indian women, finds the international study. BMJ 2013, 346, f1900.
5. O’Connor, E.; Gaynes, B.N.; Burda, B.U.; Soh, C.; Whitlock, E.P. Screening for and treatment of suicide risk relevant to primary care: A systematic review for the U.S. Preventive Services Task Force. Intern. Med. 2013, 158, 741–754.
6. Segoviano-Mendoza, M.; Cárdenas-de la Cruz, M.; Salas-Pacheco, J.; Vázquez-Alaniz, F.; La Llave-León, O.; Castellanos-Juárez, F.; Méndez-Hernández, J.; Barraza-Salas, M.; Miranda-Morales, E.; Arias-Carrión, O.; et al. Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population. BMC Psychiatry 2018, 15, 7.
7. Baek, J.H.; Kang, E.S.; Fava, M.; Mischoulon, D.; Nierenberg, A.A.; Yu, B.H.; Lee, D.; Jeon, H.J. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Neuro-Psychopharmacol. Biol. Psychiatry. 2014, 51, 113–118.
8. Koweszko, T.; Gierus, J.; Zalewska, A.; Maciejczyk, M.; Waszkiewicz, N.; Szulc, A. The Relationship between Suicide and Oxidative Stress in a Group of Psychiatric Inpatients. Clin. Med. 2020, 28, 3462.
9. Shrivastava, A.; Johnston, M.; Campbell, R.; De Sousa, A.; Shah, N. Serum cholesterol and Suicide in first episode psychosis: A preliminary study. Indian J. Psychiatry 2017, 59, 478–482.
10. Weng, J.C.; Chou, Y.S.; Tsai, Y.H.; Lee, C.T.; Hsieh, M.H.; Chen. V.C. Connectome Analysis of Brain Functional Network Alterations in Depressive Patients with Suicidal Attempt. Clin. Med. 2019, 14, 1966.
11. Yi, S.-W. Depressive symptoms on the geriatric depression scale and suicide deaths in older middle-aged men: A prospective cohort study. Prev. Med. Public Health 2016, 49, 176–182.
12. Asellus. P.; Nordstrom. P.; Jokinen, J. Cholesterol and CSF 5-HIAA in attempted suicide. Affect. Disord. 2010, 125, 388–392.
13. Lee, H.J.; Kim, Y.K. Serum lipid levels and suicide attempts. Acta Psychiatr. Scand. 2003, 108, 215–221.
14. Huang, T.L. Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes. Affect. Disord. 2005, 86, 75–79.
15. De Berardis, D.; Marini, S.; Piersanti, M.; Cavuto, M.; Perna, G.; Valchera, A.; Mazza, M.; Fornaro, M.; Iasevoli, F.; Martinotti, G.; et al. The Relationships between Cholesterol and Suicide: An Update. ISRN Psychiatry 2012, 2012, 387901.
16. Park, Y.M.; Lee, B.H.; Lee, S.H. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. J. Affect. Disord. 2014, 159, 62–65.
17. Tomson-Johanson, K.; Harro, J. Low cholesterol, impulsivity and violence revisited. Opin. Endocrinol. Diabetes Obes. 2018, 25, 103–107.
18. Svensson, T.; Inoue, M.; Sawada, N.; Charvat, H.; Mimura, M.; Tsugane, S. High serum total cholesterol is associated with suicide mortality in Japanese women. Acta Psychiatr. Scand. 2017, 136, 259–268.
19. Engel, D.F.; de Oliveira, J.; Lopes, J.B.; Santos, D.B.; Moreira, E.L.G.; Farina, M.; Rodrigues, A.L.S.; de Souza Brocardo, P.; de Bem, A.F. Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr −/− mouse experimental model. Brain Res. 2016, 311, 31–38.
20. Mathew, B.; Srinivasan, K.; Pradeep, J.; Thomas, T.; Mandal, A.K. Suicidal behaviour is associated with decreased esterified cholesterol in plasma and membrane fluidity of platelets. Asian J. Psychiatry 2018, 32, 105–109.
21. Mouritsen, O.G.; Zuckermann, M.J. What’s so special about cholesterol? Lipids 2004, 9, 1101–1113.
22. Mukherjee, S.; Maxfield, F.R. Membrane domains. Rev. Cell Dev. Biol. 2004, 20, 839–866.
23. Jacobson, K.; Mouritsen, O.G.; Anderson, R.G.W. Lipid rafts: At a crossroad between cell biology and physics. Cell Biol. 2007, 9, 7–14.
24. Lingwood, D.; Simons, K. Lipid rafts as a membrane-organizing principle. Science 2010, 327, 46–50.
25. Jafurulla, M.; Tiwari, S.; Chattopadhyay, A. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biophys. Res. Commun. 2011, 404, 569–573.
26. Allen, J.A.; Halverson-Tamboli, R.A.; Rasenick, M.M. Lipid raft microdomains and neurotransmitter signalling. Rev. Neurosci. 2007, 8, 128–140.
27. Pucadyil, T.J.; Chattopadhyay, A. Cholesterol modulates the ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biophys. Acta 2004, 1663, 188–200.
28. Pucadyil, T.J.; Chattopadhyay, A. Role of cholesterol in the function and organization of G-protein coupled receptors. Lipid Res. 2006, 45, 295–333.
29. Pucadyil, T.J.; Chattopadhyay, A. Cholesterol depletion induces dynamic confinement of the G-protein coupled serotonin1A receptor in the plasma membrane of living cells. Biophys. Acta 2007, 1768, 655–668.
30. Paila, Y.D.; Murty, M.R.; Vairamani, M.; Chattopadhyay, A. Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Optiz Syndrome. Biophys. Acta 2008, 1778, 1508–1516.
31. Paila, Y.D.; Chattopadhyay, A. Membrane cholesterol in the function and organization of G-protein coupled receptors. Biochem. 2010, 51, 439–466.
32. Shrivastava, S.; Pucadyil, T.J.; Paila, Y.D.; Ganguly, S.; Chattopadhyay, A. Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin 1A receptors. Biochemistry 2010, 49, 5426–5435.
33. Tarrier, N.; Khan, S.; Cater, J.; Picken, A. The subjective consequences of suffering a first episode psychosis: Trauma and suicide behaviour. Psychiatry Psychiatr. Epidemiol. 2007, 42, 29–35.
34. Shrivastava, A.; Shah, N.; Johnston, M.; Stitt, L.; Thakar, M. Predictors of long-term outcome of first-episode schizophrenia: A ten-year follow-up study. Indian J. Psychiatry 2010, 52, 320–326.
35. Grattan, R.E.; Lara, N.; Botello, R.M.; Tryon, V.L.; Maguire, A.M.; Carter, C.S.; Niendam, T.A. A History of Trauma is Associated with Aggression, Depression, Non-Suicidal Self-Injury Behavior, and Suicide Ideation in First-Episode Psychosis. Clin. Med. 2019, 23, 1082.
36. Messaoud, A.; Mensi, R.; Mrad, A.; Mhalla, A.; Azizi, I.; Amemou, B.; Trabelsi, I.; Grissa, M.H.; Salem, N.H.; Chadly, A.; et al. Is low total cholesterol levels associated with suicide attempt in depressive patients? Gen. Psychiatry 2017, 16, 20.
37. Bartoli, F.; Di Brita, C.; Crocamo, C.; Clerici, M.; Carrà, G. Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2017, 79, 90–95.
38. Golomb, B.A. Cholesterol and violence: Is there a connection? Intern. Med. 1998, 128, 478–487.
39. Repo-Tiihonen, E.; Halonen, P.; Tiihonen, J.; Virkkunen, M. Total serum cholesterol level, violent criminal offences, suicidal behavior, mortality and the appearance of conduct disorder in Finnish male criminal offenders with antisocial personality disorder. Arch. Psychiatry Clin. Neurosci. 2002, 252, 8–11.
40. Suneson, K.; Asp, M.; Träskman-Bendz, L.; Westrin, Å.; Ambrus, L.; Lindqvist, D. Low total cholesterol and low-density lipoprotein associated with aggression and hostility in recent suicide attempters. Psychiatry Res. 2019, 273, 430–434.
41. Bonow, R.O.; Zipes, D.P.; Libby, P.; Mann, D.L.; Tomaselli, G.F. (Eds.) Risk markers and the primary prevention of cardiovascular disease. In Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 11th ed.; Saunders Elsevier: Philadelphia, PA, USA, 2019.
42. Bartoli, F.; Crocamo, C.; Dakanalis, A.; Riboldi, I.; Miotto, A.; Brosio, E.; Clerici, M.; Carrà, G. Association between total serum cholesterol and suicide attempts in subjects with major depressive disorder: Exploring the role of clinical and biochemical confounding factors. Biochem. 2017, 50, 274–278.
43. Knowles, E.E.M.; Curran, J.E.; Meikle, P.J.; Huynh, K.; Mathias, S.R.; Göring, H.H.H.; VandeBerg, J.L.; Mahaney, M.C.; Jalbrzikowski, M.; Mosior, M.K.; et al. Disentangling the genetic overlap between cholesterol and suicide risk. Neuropsychopharmacology 2018, 43, 2556–2563.
44. Aguglia, A.; Solano, P.; Giacomini, G.; Caprino, M.; Conigliaro, C.; Romano, M.; Aguglia, E.; Serafini, G.; Amore, M. The Association Between Dyslipidemia and Lethality of Suicide Attempts: A Case-Control Study. Psychiatry 2019, 10, 70.
45. Aguglia, A.; Solano, P.; Parisi, V.M.; Asaro, P.; Caprino, M.; Trabucco, A.; Amerio, A.; Amore, M.; Serafini, G. Predictors of relapse in high lethality suicide attempters: A six-month prospective study. Affect. Disord. 2020, 271, 328–335.
46. Chen, S.; Mizoue, T.; Hu, H.; Kuwahara, K.; Honda, T.; Yamamoto, S.; Nakagawa, T.; Miyamoto, T.; Okazaki, H.; Shimizu, M.; et al. Japan Epidemiology Collaboration on Occupational Health Study Group. Serum cholesterol levels preceding to suicide death in Japanese workers: A nested case-control study. Acta Neuropsychiatr. 2019, 31, 266–269.
47. Ma, Y.J.; Wang, D.F.; Yuan, M.; Zhang, X.J.; Long, J.; Chen, S.B.; Wu, Q.X.; Wang, X.Y.; Patel, M.; Verrico, C.D.; et al. The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder. BMC Psychiatry 2019, 19, 144.
48. Reuter, C.; Caldwell, B.; Basehore, H. Evaluation of Cholesterol as a Biomarker for Suicidality in a Veteran Sample. Nurs. Health 2017, 40, 341–349.
49. Capuzzi, E.; Bartoli, F.; Crocamo, C.; Malerba, M.R.; Clerici, M.; Carrà, G. Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study. Psychiatry Res. 2018, 270, 611–615.
50. Ma, Y.J.; Zhou, Y.J.; Wang, D.F.; Li, Y.; Wang, D.M.; Liu, T.Q.; Zhang, X.Y. Association of Lipid Profile and Suicide Attempts in a Large Sample of First Episode Drug-Naïve Patients With Major Depressive Disorder. Psychiatry 2020, 11, 543632.
51. Su, M.; Li, E.; Tang, C.; Zhao, Y.; Liu, R.; Gao, K. Comparison of blood lipid profile/thyroid function markers between unipolar and bipolar depressed patients and in depressed patients with anhedonia or suicidal thoughts. Med. 2019, 25, 51.

This entry is adapted from the peer-reviewed paper 10.3390/jcm10020333